Meet the experts driving innovation at eXmoor Pharma. Our leadership, scientific, and business teams bring decades of combined experience in process development, GMP manufacturing, facility design, and consulting, working together to accelerate advanced therapies from concept to commercialisation.
About Us
Our Team
Meet Our Team
Angela Osborne
Founder and Executive Chair
Ian Rhodes
Director
Lucy Foley
Chief Executive Officer
Graham Henderson
Chief Financial Officer and Board Observer
Gavin Sutton
Executive Director Capital Projects
Gillian Lewis
Chief Consultant
Emma Ewins
Head of GMP
Charlotte Nodwell
Head of HR
David Vincent
Head of Process Development
Termeh Ahmadraji
Head of Operations
Remy Martin
Commercial Manager
Carol Elvira
Business Development Manager
Ruxandra Comisel
Consultant Analyst
Helen Jones
Marketing Manager
Shailesh Maingi
Board Observer, Kineticos Ventures
Tom Casdagli
Board Member, MVM Partners
Frank Lis
Board Member, Kineticos Ventures
Jack Tanaka
Board Member, MVM Partners
James Miskin
Non-Executive Director
Kate Fynes
Senior CMC Translation Consultant
Ryan Guest
Senior CMC Translation Consultant
Clare Blue
Senior CMC Translation Consultant
Harvey Branton
Senior Translation Consultant
Chrissy Claudius
Project Manager
Robert Scott
Head of Translation Consultancy
Drew Hope
Senior Bio Manufacturing & Compliance Consultant & UK QP
Evelien Stalmeijer
Chief Cell & Gene Therapy Consultant
Vittoria Ardissone
GMP Compliance Consultant and QP
John Joseph
Bioprocessing Engineering Consultant
Paul Dempsey
Architect
Andrew Besso
Senior Bioprocess Consultant
Daphné Bocciarelli
Head of Vector
Adam Janvier
Head of Cell Therapy
Corinne McEwan
Head of RNA
Let’s Accelerate Your Therapy Together
Whether you’re in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
